Comprehensive DNA copy number profiling of meningioma using a chromosome 1 tiling path microarray identifies novel candidate tumor suppressor loci

Cancer Research

Volumn 65, Issue 7, 2005, Pages 2653-2661

  Buckley, Patrick G ^a   Jarbo, Caroline ^a   Menzel, Uwe ^a   Mathiesen, Tiit ^b   Scott, Carol ^c   Gregory, Simon G ^c,d   Langford, Cordelia F ^c   Dumanski, Jan P ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CELL HETEROGENEITY; CHROMOSOME 1; CHROMOSOME 1P; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME LOSS; CHROMOSOME SIZE; DNA FINGERPRINTING; DNA MICROARRAY; FEMALE; GENE LOCUS; GENE NUMBER; GENETIC ANALYSIS; GENOME; HOMOZYGOSITY; HUMAN; HUMAN CELL; MALE; MENINGIOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 1; DNA, NEOPLASM; GENE DELETION; GENE DOSAGE; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; MENINGEAL NEOPLASMS; MENINGIOMA; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, GENETIC;

EID: 16844364521     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-3651     Document Type: Article

References (49)

1. Louis D, Scheithauer B, Budka H, von Deimling A, Kepes J. Meningioma. In: Kleihues P, Cavenee W, editors. World Health Organization classification of tumors: tumors of the nervous system. Lyon: IARC Press; 2000. p. 176-84.
2. Rausing A, Ybo W, Stenflo J. Intracranial meningioma: a population study of ten years. Acta Neurol Scand 1970;46:102-10.
3. Evans DG, Huson SM, Donnai D, et al. A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet 1992;29:841-6.
4. Evans DG, Huson SM, Donnai D, et al. A clinical study of type 2 neurofibromatosis. Quaterly J Med 1992;84:603-18.
5. Parry DM, Eldridge R, Kaiser-Kupfer M, Bouzas EA, Pikus A, Patronas N. Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet 1994;52:450-61.
6. Ruttledge MH, Sarrazin J, Rangaratnam S, et al. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet 1994;6:180-4.
7. Lekanne Deprez RH, Bianchi AB, Groen NA, et al. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet 1994;54:1022-9.
8. Wellenreuther R, Kraus JA, Lenartz D, et al. Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Pathol 1995;146:827-32.
9. Papi L, De VL, Vitelli F, et al. Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas. Hum Genet 1995;95:347-51.
10. De Vitis L, Tedde A, Vitelli F, et al. Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas. Hum Genet 1996;97:632-7.
11. Ruttledge MH, Xie YG, Han FY, et al. Deletions on chromosome 22 in sporadic meningioma. Genes Chromosomes Cancer 1994;10:122-30.
12. Akagi K, Kurahashi H, Arita N, et al. Deletion mapping of the long arm of chromosome 22 in human meningiomas. Int J Cancer 1995;60:178-82.
13. Lindblom A, Ruttledge M, Collins VP, Nordenskjold M, Dumanski JP. Chromosomal deletions in anaplastic meningiomas suggest multiple regions outside chromosome 22 as important in tumor progression. Int J Cancer 1994;56:354-7.
14. Sulman EP, Dumanski JP, White PS, et al. Identification of a consistent region of allelic loss on 1p32 in meningiomas: correlation with increased morbidity. Cancer Res 1998;58:3226-30.
15. Ishino S, Hashimoto N, Fushiki S, et al. Loss of material from chromosome arm 1p during malignant progression of meningioma revealed by fluorescent in situ hybridization. Cancer 1998;83:360-6.
16. Bello MJ, de Campos JM, Vaquero J, Kusak ME, Sarasa JL, Rey JA. High-resolution analysis of chromosome arm 1p alterations in meningioma. Cancer Genet Cytogenet 2000;120:30-6.
17. Solinas-Toldo S, Lampel S, Stilgenbauer S, et al. Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 1997;20:399-407.
18. Pinkel D, Segraves R, Sudar D, et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 1998;20:207-11.
19. Buckley PG, Mantripragada KK, Benetkiewicz M, et al. A full-coverage, high-resolution human chromosome 22 genomic microarray for clinical and research applications. Hum Mol Genet 2002;11:3221-9.
20. Hurst CD, Fiegler H, Carr P, Williams S, Carter NP, Knowles MA. High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization. Oncogene 2004;23:2250-63.
21. Paris PL, Andaya A, Fridlyand J, et al. Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors. Hum Mol Genet 2004;13:1303-13.
22. De Leeuw RJ, Davies JJ, Rosenwald A, et al. Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes. Hum Mol Genet 2004;13:1827-37.
23. Iafrate AJ, Feuk L, Rivera MN, et al. Detection of large-scale variation in the human genome. Nat Genet 2004;36:931-2.
24. Marra MA, Kucaba TA, Dietrich NL, et al. High throughput fingerprint analysis of large-insert clones. Genome Res 1997;7:1072-84.
25. Gregory SG, Howell GR, Bentley DR. Genome mapping by fluorescent fingerprinting. Genome Res 1997;7:1162-8.
26. Soderlund C, Longden I, Mott R. FPC: a system for building contigs from restriction fingerprinted clones. Comput Appl Biosci 1997;13:523-35.
27. Fiegler H, Carr P, Douglas EJ, et al. DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones. Genes Chromosomes Cancer 2003;36:361-74.
28. Shaw-Smith C, Redon R, Rickman L, et al. Microarray based comparative genomic hybridisation (array-CGH) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic features. J Med Genet 2004;41:241-8.
29. Dumanski JP, Carlbom E, Collins VP, Nordenskjold M. Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningioma. Proc Natl Acad Sci U S A 1987;84:9275-9.
30. Dumanski JP, Rouleau GA, Nordenskjold M, Collins VP. Molecular genetic analysis of chromosome 22 in 81 cases of meningioma. Cancer Res 1990;50:5863-7.
31. Sulman EP, White PS, Brodeur GM. Genomic annotation of the meningioma tumor suppressor locus on chromosome 1p34. Oncogene 2004;23:1014-20.
32. Lupski JR. Genomic disorders: structural features of the genome can lead to DNA rearrangements and human disease traits. Trends Genet 1998;14:417-22.
33. Dunham I, Shimizu N, et al. The DNA sequence of human chromosome 22. Nature 1999;402:489-95.
34. Shaikh TH, Kurahashi H, Saitta SC, et al. Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis. Hum Mol Genet 2000;9:489-501.
35. Lopez-Correa C, Dorschner M, Brems H, et al. Recombination hotspot in NF1 microdeletion patients. Hum Mol Genet 2001;10:1387-92.
36. Bailey JA, Yavor AM, Viggiano L, et al. Human-specific duplication and mosaic transcripts: the recent paralogous structure of chromosome 22. Am J Hum Genet 2002;70:83-100.
37. Lekanne Deprez RH, Riegman PH, van Drunen E, et al. Cytogenetic, molecular genetic and pathological analyses in 126 meningiomas. J Neuropathol Exp Neurol 1995;54:224-35.
38. Wu JK, MacGillavry M, Kessaris C, Verheul B, Adelman LS, Darras BT. Clonal analysis of meningiomas. Neurosurg 1996;38:1196-200; discussion 200-1.
39. Sayagues JM, Tabernero MD, Maillo A, et al. Incidence of numerical chromosome aberrations in meningioma tumors as revealed by fluorescence in situ hybridization using 10 chromosome-specific probes. Cytometry 2002;50:153-9.
40. Hodgson G, Hager JH, Volik S, et al. Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nat Genet 2001;29:459-64.
41. Mantripragada KK, Buckley PG, Benetkiewicz M, et al. High-resolution profiling of an 11 Mb segment of human chromosome 22 in sporadic schwannoma using array-CGH. Int J Oncol 2003;22:615-22.
42. Benetkiewicz M, Wang Y, Schaner M, et al. High-resolution gene copy number and expression profiling of human chromosome 22 in ovarian carcinomas. Genes Chromosomes Cancer 2005;42:228-37.
43. Groot PC, Mager WH, Frants RR. Interpretation of polymorphic DNA patterns in the human α-amylase multigene family. Genomics 1991;10:779-85.
44. Schwab M, Praml C, Amler LC. Genomic instability in 1p ad human malignacies. Genes Chromosomes Cancer 1996;16:211-29.
45. Alonso ME, Bello MJ, Gonzalez-Gomez P, et al. Mutation analysis of the p73 gene in nonastrocytic brain tumours. Br J Cancer 2001;85:204-8.
46. Lomas J, Bello MJ, Arjona D, et al. Analysis of p73 gene in meningiomas with deletion at Ip. Cancer Genet Cytogenet 2001;129:88-91.
47. Mantripragada KK, Buckley PG, Jarbo C, Menzel U, Dumanski JP. Development of NF2 gene specific, strictly sequence defined diagnostic microarray for deletion detection. J Mol Med 2003;81:443-51.
48. Mantripragada KK, Tapia-Páez I, Blennow E, Nilsson P, Wedell A, Dumanski J. DNA copy-number analysis of the 22q11 deletion-syndrome region using array-CGH with genomic and PCR-based targets. Int J Mol Med 2004;13:273-9.
49. Ishkanian AS, Malloff CA, Watson SK, et al. A tiling resolution DNA microarray with complete coverage of the human genome. Nat Genet 2004;36:299-303.